Celebrating 25 years of discoveries

2021 was a landmark year...

We were still combatting the devastating impact of COVID-19, but it also brought cause for celebration. Cabrini Research celebrated an incredible 25 years of research discoveries that have saved lives, made headlines and, ultimately, paved the way for research into the future.

First established in 1996, by the inaugural Institute Director Associate Professor Doug Lording AM – an esteemed endocrinologist/andrologist and committed clinician researcher at Cabrini Health, we have evolved greatly during the past 25 years.

What was started by one incredibly committed clinician researcher is now home to multiple research departments, working in clinical disciplines across the full trajectory of translational research. Despite COVID-19 lockdowns and restrictions throughout the year, we were able to come together to celebrate this momentous milestone with an evening gala event in December 2021. Held at Kooyong Tennis Club, the evening brought together our Cabrini team and researchers, led by Group Director Cabrini Research, Professor Gary Richardson OAM,, together with the people who have made incredible contributions to our success including past directors A/Prof Doug Lording AM and Associate Professor Peter Lowthian, and our esteemed guests, many of whom are our long-term supporters, to whom we are indebted. The evening provided much entertainment, with comedy and singing by the Singing

Sommeliers and a deeply insightful and interesting presentation by our keynote speaker Professor Allen Cheng, Professor of Infectious Diseases Epidemiology at Monash University and The Alfred, and former Victorian Deputy Chief Health Officer. Allen was incredibly engaging, speaking about the most difficult phase of the pandemic and the positives that could be taken from it, especially the research efforts.

At Cabrini Research, we are striving to be a leader in research which improves patient outcomes, healthcare practices and healthcare sustainability worldwide. We are embarking on new and ambitious research programs aligned to our clinical services and we maintain our continued pursuit to make ground-breaking discoveries.